Gemtuzumab Ozogamicin in NPM1-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09–09 Phase III Study - Schlenk, RF; Paschka, P; Krzykalla, J (J Clin Oncol Off J Am Soc Clin Oncol, 2020)
et al.